• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Neurocrine Biosciences

Neurocrine Biosciences

Neurocrine Biosciences Inc NBIX

Last Price$59.03Day Change (%)0.12%
Open Price$58.59Day Change ($)0.07
Day Range57.71–60.5652-Week Range37.34–63.77

As of Fri 10/20/2017 5:24:00 PM | USD

  1. UPDATE: U.S. benchmarks take flight, charting -2-

    UPDATE: U.S. benchmarks take flight, charting -2-

  2. UPDATE: U.S. benchmarks take flight, charting the approach of Dow 23,000

    UPDATE: U.S. benchmarks take flight, charting the approach of Dow 23,000

  3. UPDATE: This drug may be able to treat both women's health disorders and prostate cancer

    UPDATE: This drug may be able to treat both women's health disorders and prostate cancer

  4. UPDATE: This drug may be able to treat both women's health disorders and prostate cancer

    UPDATE: This drug may be able to treat both women's health disorders and prostate cancer

  5. UPDATE: This drug may be able to treat both women's health disorders and prostate cancer

    UPDATE: This drug may be able to treat both women's health disorders and prostate cancer

  6. UPDATE: This drug may be able to treat both women's health disorders and prostate cancer

    UPDATE: This drug may be able to treat both women's health disorders and prostate cancer

  7. Charting the S&P 500's break to 'clear skies' -2-

    Charting the S&P 500's break to 'clear skies' -2-

  8. Charting the S&P 500's break to 'clear skies' technical territory

    Charting the S&P 500's break to 'clear skies' technical territory

  9. Neurocrine stock up 3% on higher-dose approval of tardive dyskinesia drug

    Neurocrine stock up 3% on higher-dose approval of tardive dyskinesia drug

12

©2017 Morningstar Advisor. All right reserved.